The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort Studies
Abstract:Marc Rodger and colleagues report the results of their systematic review and meta-analysis of prospective cohort studies that estimated the association of maternal factor V Leiden and prothrombin gene mutation carrier status and placenta-mediated pregnancy complications.
“…A pooled odds ratio estimate of 1.13 and wide 95 % Confidence Interval of 0.64-2.01 for the association for the prothrombin gene mutation and pregnancy loss was reported. The mutation was found to have no association with pre-eclampsia (OR = 1.25, 95% CI 0.79-1.99) or for neonates deemed small for gestational age (OR 1.25, 95% CI 0.92-1.70) (Rodger et al, 2010).…”
“…A pooled odds ratio estimate of 1.13 and wide 95 % Confidence Interval of 0.64-2.01 for the association for the prothrombin gene mutation and pregnancy loss was reported. The mutation was found to have no association with pre-eclampsia (OR = 1.25, 95% CI 0.79-1.99) or for neonates deemed small for gestational age (OR 1.25, 95% CI 0.92-1.70) (Rodger et al, 2010).…”
pregnancy events [2]. Clinical miscarriages may be subdivided into early clinical pregnancy losses (before gestational week 12) and late clinical pregnancy losses (gestational weeks 12 to 21). The term miscarriage is preferred rather than abortion both by patients and physicians, although "spontaneous abortion" is still used in scientific literature [3,4].For more than 30 years, controversy has existed on the number of miscarriages required to define RM and when diagnostic testing is warranted [5]
EpidemiologyEarly pregnancy loss is perhaps the most common obstetric complication, occurring in over two-thirds of human conceptions. Approximately 15 -20% of all clinically recognized pregnancies will end in a miscarriage [4,9,10]. However, prospective cohort studies using sensitive and specific daily urinary hCG assays in women trying to conceive have demonstrated that only around one-third of conceptions progress to a live birth. Most of the losses occur before the clinical recognition of pregnancy as implantation failures. An estimated 30% of human conceptions are lost prior to implantation and a further 30% following implantation but before the missed menstrual period, that is in the third or fourth week of gestation. These are often termed preclinical losses [11].The risk of sporadic miscarriage between 6 and 12 weeks of gestation in women less than 35 years of age is 9% to 12%. The risk increases with age. In women older than 40 years of age, the sporadic miscarriage rate approaches 50%. Late losses between 12 and 22 weeks occur less frequently and constitute around 4% of pregnancy outcomes [4,9].Compared to sporadic miscarriage the prevalence of RM is considerably lower irrespective of whether biochemical losses are included or not. Approximately 1% of all women trying to conceive have recurrent miscarriage, defined as three previous miscarriages; when recurrent miscarriage is defined as two previous miscarriages, the proportion rises to 3% [12,13].
EtiologyMultiple potential etiologies for RM have been described (Table 1). As a consequence, several recommendations have been published regarding the evaluation and management of RM [3].The potential etiologies of RM can be divided into embryologically driven causes (mainly due to an abnormal embryonic karyotype) and maternally driven causes which affect the endometrium and/or placental development [14,15]. Thus, studies that focus on RM have Barrenetxea G, et al., J Reprod Med Gynecol Obstet 2017
AbstractHuman reproduction is characterized by its inefficiency. The loss of pregnancy at any stage can be a devastating experience and particular sensitivity is required in assessing and counseling couples with Recurrent Miscarriage (RM). Recurrent Miscarriage (RM) represents a clinical challenge for physicians not only because there are multiple possible etiologies, but also because the diagnostic testing is costly and time consuming. Despite several well-known etiologic factors, the cause of RM cannot be determined in almost 50% of cases. Multiple potential etiolo...
“…Esses polimorfismos têm sido associados a eventos tromboembólicos como a TVP, trombose arterial e venosa, bem como a embolia pulmonar. Eles também exercem um importante papel nos AERs relacionados com complicações vasculares da placenta, como a excessiva trombose dos vasos placentários, o infarto placentário e a insuficiência uteroplacentária (Smith et al, 2007;Rodger et al, 2010;Dahm et al, 2012;Sode et al, 2013).…”
Section: Discussionunclassified
“…A associação entre a presença de trombofilias (polimorfismos genéticos tais como o FVL e protrombina) e complicações obstétricas de origem placentária tem sido descrita na literatura (Rodger et al, 2010).…”
Section: Diminui a Concentração Anticoagulaçãounclassified
“…Apesar de todos os fatores citados acima estarem relacionadas aos AER, cerca de 40 a 50% dos casos permanecem sem explicação e são classificados como AER idiopático (Lin, 1993;Rai e Regan, 2006;Flood et al, 2010;Musters et al, 2011 incapacidade da placenta em prover oxigenação e nutrição adequada ao feto (Brenner, 2004;Rodger et al, 2010).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.